Genscript Biotech (OTCMKTS:GNNSF) Stock Price Down 15.5% – Here’s What Happened

Genscript Biotech Co. (OTCMKTS:GNNSF)’s share price was down 15.5% during trading on Monday . The stock traded as low as C$1.31 and last traded at C$1.31. Approximately 200 shares traded hands during mid-day trading, a decline of 98% from the average daily volume of 9,917 shares. The stock had previously closed at C$1.55.

Genscript Biotech Stock Performance

The stock has a 50-day moving average price of C$1.74 and a 200 day moving average price of C$2.02.

Genscript Biotech Company Profile

GenScript Biotech Corporation is a global contract research, development and manufacturing organization (CDMO) specializing in synthetic biology and biopharmaceutical services. Founded in 2002, the company provides end-to-end solutions that span gene and peptide synthesis, recombinant protein expression, custom antibody discovery and cell line development. GenScript’s integrated platforms support early-stage discovery through to process development, enabling academic institutions, biotech innovators and pharmaceutical companies to accelerate research timelines.

The company’s core offerings include molecular biology services such as DNA construction, gene editing using CRISPR/Cas9 technology and high-throughput peptide libraries.